Abstract. In vivo testing for resistance of Plasmodium falciparum to co-trimoxazole (trimethoprim/sulfamethoxazole) was performed in Uganda in 41 children with uncomplicated malaria, and blood samples were screened before and after treatment for polymorphisms in the antifolate target genes for dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS). Selection towards a specific genotype at some codons of the DHFR and DHPS genes was observed in samples collected after exposure to co-trimoxazole drug pressure. The alleles 51-isoleucine, 59-arginine, and 108-serine of DHFR were significantly associated with clinical resistance, as was allele 581-alanine of DHPS. Resistance against antifolate combinations probably requires resistance-related polymorphisms in both the DHFR and the DHPS genes. In addition, it appears that the trimethoprim-resistant DHFR genotype differs from that for pyrimethamine at residue 108.Falciparum malaria and acute respiratory tract infection, two of the most common causes of childhood morbidity and mortality in sub-Saharan Africa, show an overlap of symptoms in a high proportion of cases. 1 The World Health Organization (WHO) recommends co-trimoxazole (trimethoprim and sulfamethoxazole) as treatment for children in malaria-endemic areas presenting with fever and respiratory symptoms. 2 This drug has been shown in the past to be effective against malaria as well as pneumonia. 3,4 The components of co-trimoxazole target selectively dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS), the same folate pathway enzymes as pyrimethamine/sulfadoxine, which is used in many African countries for treatment of chloroquine-resistant infections with Plasmodium falciparum. In vitro drug resistance of P. falciparum to pyrimethamine has been associated with point mutations in the gene coding for DHFR, in particular with the presence of asparagine in position 108.5 Likewise, polymorphisms at 5 highly conserved positions within DHPS have been reported in sulfadoxine-resistant isolates of P. falciparum: codons 436, 437, 581, 613, 6,7 and 540. [8][9][10] Unlike DHFR, no single polymorphism has been associated with all resistant strains and only limited data are available on the global distribution of these polymorphisms.11 In vivo testing for resistance to co-trimoxazole was performed in rural health centers in the 2 districts of Kabarole and Bundibugyo in western Uganda. Results of the clinical and parasitologic outcomes have been reported elsewhere.12 Fortyone children with symptomatic malaria from the Kabarole and Bundibugyo Districts of western Uganda were recruited for the study. Data were obtained about polymorphisms in the DHFR and DHPS genes that have been associated with antifolate resistance [5][6][7][13][14][15][16][17][18][19] by extraction and amplification of parasite DNA from filter paper and thick blood films. We report on a comparison of the prevalence of polymorphisms of the antifolate target genes at days 0 and 3/7 and their association with in vivo results in one...